is rybelsus a glp 1 drug (semaglutide) Lilly's GLP-1 pill tops Novo's

Patients also stop because of cost, loss of insurance, or side effects

Loss of lean muscle mass has been noted in up to 25% of patients undergoing rapid weight loss

[DOI] [PubMed] [Google Scholar] 97.Kazda C.M., Ding Y., Kelly R.P., Garhyan P., Shi C., Lim C.N., Fu H., Watson D.E., Lewin A.J., Landschulz W.H., et al

The gastrointestinal effects of GLP-1 agonistsincluding delayed gastric emptying and altered bowel transit timehave raised questions about whether chronic exposure might influence colorectal cancer risk

The affluent self-pay customer, growing awareness of chronic diseases, and the demand for once-daily injectable therapies all contribute to market growth

Heres what Ive found works consistently with clients on semaglutide and tirzepatide